Strix
26.1K

CVE-2026-24217

HIGHCVSS 8.8/10EPSS 0.76%

Last modified

CVE-2026-24217 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.. EPSS estimates a 0.76% chance of exploitation in the next 30 days.

Description

NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

EPSS Probability
0.76%

50.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
NvidiaBionemo Framework< 2026-04-03

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2026-24217?
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
How severe is CVE-2026-24217?
CVE-2026-24217 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.76% probability of exploitation in the next 30 days.
How do I fix CVE-2026-24217?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2026-24217?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST